TC

Tata Chemicals

Q1 FY27Chemicals & Petrochemicals

Tata Chemicals Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹627
Market cap₹16.0K Cr
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Future Growth Expectations from Tata Chemicals Limited Q1 FY27 Earnings Call: - India Business: - Positive volume growth driven by demand across products. The India business shows strong volume growth and higher realizations, supporting earnings growth despite cost pressures.

From Tata Chemicals's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
Future Growth Expectations from Tata Chemicals Limited Q1 FY27 Earnings Call: - **India Business:** - Positive volume growth driven by demand across products. - Higher realization expected due to pricing adjustments linked to import parity. - Growth in salt volumes and favorable conditions in food, feed, pharma. - Focus on non-cyclical products like silica and specialty segments. - Expansion projects like 82.5 KTPA salt plant operational by year-end; silica plant by 2028. - **US Business:** - Stable domestic volumes with steady pricing; export volumes supported by LATAM and Northeast Asia. - Margins under pressure from logistics cost but volumes steady. - Southeast Asian export volume reduced due to Chinese competition. - **Global Soda Ash Market:** - Oversupply expected to continue, especially from China, keeping pricing subdued. - Long-term demand positive due to renewable energy and electrification focus. - LATAM demand strengthened with rising lithium carbonate production. - **IMACID Business:** - Operations resumed but margins under pressure due to high sulfur prices; expected profitability by year-end.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Tata Chemicals said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • FY27 capex planned to be around INR 1,200 crores, aligned with depreciation; aim to stay below this level (Page 14).
  • Liquidation of INR 300 crores investments (stock and land) planned to support financials (Page 14).
  • Non-core land monetization expected in the second half of FY27, post Q2 (Page 14).
  • Salt plant in India (82.5 KTPA) expected operational by end of 2026, supplying market by Q1 FY28 (Page 7).
  • South India salt plant (210 KTPA) and 50 KTPA silica plant to become operational in 2028 (Page 7).
  • Capex focus shifting towards Living Essentials (food, feed, pharma) over Industrial Essentials, aiming to de-commoditize portfolio and reduce cyclicality (Page 6).

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Solar Industries
Rev 2Mar 1
3
Rev 2Mar 1
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Tata Chemicals said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from Tata Chemicals Limited's Q1 FY27 earnings call does not mention any details regarding the current or expected order book or pending orders. There is no information or discussion on order backlog, order inflow, or pending contracts in the text on pages 1 through 15 of the document. The focus is primarily on operational performance, market outlook, product segments, pricing, raw material cost, capex plans, and technology development such as sodium-ion batteries. Hence, no data or commentary related to order book or pending orders is available from the given transcript.

Tata Chemicals — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹3.4K Cr, net loss ₹2.1K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Tata Chemicals Q1 FY27 results?

Future Growth Expectations from Tata Chemicals Limited Q1 FY27 Earnings Call: - India Business: - Positive volume growth driven by demand across products. The India business shows strong volume growth and higher realizations, supporting earnings growth despite cost pressures.

What is Tata Chemicals share price analysis?

Tata Chemicals currently shows a below-average growth signal. The stock trades at a P/E of N/A with a market cap of ₹15,967 Cr. Investors should review the full earnings analysis for detailed insights.

Is Tata Chemicals planning capital expenditure?

FY27 capex planned to be around INR 1,200 crores, aligned with depreciation; aim to stay below this level (Page 14).

Keep Tata Chemicals on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.